SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-003240
Filing Date
2023-05-10
Accepted
2023-05-10 16:22:49
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1128102
2 CERTIFICATION vnrx_ex311.htm EX-31.1 9929
3 CERTIFICATION vnrx_ex312.htm EX-31.2 9936
4 CERTIFICATION vnrx_ex321.htm EX-32.1 5440
  Complete submission text file 0001477932-23-003240.txt   5862366

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20230331.xsd EX-101.SCH 72316
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20230331_lab.xml EX-101.LAB 360435
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20230331_cal.xml EX-101.CAL 48093
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20230331_pre.xml EX-101.PRE 322359
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20230331_def.xml EX-101.DEF 224889
60 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 984303
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 23906818
SIC: 2835 In Vitro & In Vivo Diagnostic Substances